Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huangjia Ruangan Granules
- Development stage
- Unknown
- Lead developer
- Weikang Pharmaceutical
- Administration
- Oral
01
Overview
Huangjia Ruangan Granules is a Traditional Chinese Medicine (TCM) formulation developed by Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine for the treatment of chronic hepatitis B-associated liver fibrosis. The formulation is specifically designed to address the TCM syndrome of liver stagnation and spleen deficiency combined with blood stasis and collateral obstruction. It is currently being investigated in Phase II clinical trials as an adjunctive therapy to nucleoside analogs like entecavir. The granules aim to exert anti-fibrotic effects by modulating inflammatory pathways and reducing the accumulation of extracellular matrix in the liver, thereby improving liver stiffness and histological outcomes in patients with chronic hepatitis B.
- Brand names
- Huangjia Ruangan Granules
- Other names
- Huangjia Ruangan Keli黄甲软肝颗粒
02
Targets
NF-κBMAPK3 (Mitogen-activated protein kinase 1)TNFRSF1A (Tumor necrosis factor receptor superfamily member 1A)
Beyond the preview
Go deeper on Huangjia Ruangan Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Huangjia Ruangan Granules.